Extracorporeal Membrane Oxygenation for Patients With COVID-19 in Severe Respiratory Failure

Asif K Mustafa; Philip J Alexander; Devang J Joshi; Deborah R Tabachnick; Chadrick A Cross; Pat S Pappas; Antone J Tatooles

doi:10.1001/jamasurg.2020.3950

Extracorporeal Membrane Oxygenation for Patients With COVID-19 in Severe Respiratory Failure

JAMA Surg. 2020 Oct 1;155(10):990-992. doi: 10.1001/jamasurg.2020.3950.

Authors

Asif K Mustafa^{1

2}, Philip J Alexander^{1

2}, Devang J Joshi^{1

2}, Deborah R Tabachnick^{1

2}, Chadrick A Cross^{1

2}, Pat S Pappas^{1

2}, Antone J Tatooles^{1

2}

Affiliations

¹ Department of Cardiovascular and Thoracic Surgery, Rush University Medical Center, Chicago, Illinois.
² Cardiothoracic and Vascular Surgical Associates SC, Advocate Christ Medical Center, Oak Lawn, Illinois.

Abstract

This cohort study examines the outcome of venovenous extracorporeal membrane oxygenation in 40 patients recently hospitalized with coronavirus disease 2019 in the US.

MeSH terms

Adult
COVID-19* / complications
Extracorporeal Membrane Oxygenation* / methods
Female
Humans
Male
Middle Aged
Respiration, Artificial
Respiratory Distress Syndrome / etiology
Respiratory Distress Syndrome / therapy*
Respiratory Insufficiency / etiology
Respiratory Insufficiency / therapy*
Retrospective Studies
SARS-CoV-2*
Young Adult